2002 Pharmaceutical research Safety 
European Pharmaceutical Review
SEPTEMBER 22, 2023
7 It is currently being evaluated in a Phase Ib/IIa clinical study, demonstrating to date a good safety profile. While favourable safety has been reported up to the Phase II, the relevance of targeting the C-terminal portion of Abeta still needs to be confirmed.
PharmaKinnex
AUGUST 23, 2022
More convenience and safety? On April 18, 2002, the Pharmaceutical Research and Manufacturers of America (PhRMA) adopted a new marketing code to govern the pharmaceutical industry’s relationships with physicians and other health care professionals…” – AMA Journal of Ethics. What’s not to love?
Expert insights. Personalized for you.
97 
Let's personalize your content